Try our Advanced Search for more refined results

Loestrin 24 FE Antitrust Litigation

  1. June 14, 2016

    Warner Chilcott Wants 'Shotgun' Antitrust Claims Tossed

    Warner Chilcott PLC on Monday asked a Rhode Island federal court to dismiss revived claims that it paid drugmakers to delay producing a generic version of its contraceptive Loestrin in multidistrict litigation, saying the “kitchen sink” of antitrust allegations suffers from fatal deficiencies.

  2. February 18, 2015

    Loestrin Buyers Teed Up For Appeal In Pay-For-Delay Suit

    A Rhode Island judge on Tuesday cleared the way for Loestrin buyers to appeal the dismissal of their pay-for-delay claims against Warner Chilcott PLC, which would see another circuit court forced to decide whether patent settlements must include cash payments to face antitrust scrutiny.

  3. September 04, 2014

    Loestrin Pay-For-Delay Case Can't Survive Actavis, Judge Says

    A Rhode Island federal judge tossed all claims in multidistrict litigation that Warner Chilcott PLC and two others entered illegal agreements to delay generic versions of Loestrin, saying his decision "was not an easy one" but the deals didn't include cash payments as specified in the U.S. Supreme Court's Actavis ruling.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!